Shree Ganesh Biotech (India) (BOM:539470) Beta: 1.9186 (As of Jul. 01, 2026)


BOM:539470 Shree Ganesh Biotech (India) Ltd BOM:539470
46 GF Score
Price ₹0.56
GF Value ₹0.20
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Shree Ganesh Biotech (India) Beta?

Shree Ganesh Biotech (India) BOM:539470 46 Beta is 1.9186 as of Jul. 01, 2026. GuruFocus rates BOM:539470 with a GF Score™ of 46/100 and a GF Value™ of ₹0.20 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-01), Shree Ganesh Biotech (India)'s Beta is 1.9186.


Shree Ganesh Biotech (India)  (BOM:539470) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Shree Ganesh Biotech (India) Beta Related Terms


Shree Ganesh Biotech (India) Beta Historical Data

* Premium members only.

The historical data trend for Shree Ganesh Biotech (India)'s Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shree Ganesh Biotech (India) Beta Chart

Shree Ganesh Biotech (India) Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.57 2.53 2.16 1.94

Shree Ganesh Biotech (India) Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.16 1.94 2.36 2.55 1.94

BOM:539470 vs CTVA, CF, MOS: Beta Comparison

For the Agricultural Inputs subindustry, Shree Ganesh Biotech (India)'s Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shree Ganesh Biotech (India) Beta vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Shree Ganesh Biotech (India)'s Beta distribution charts can be found below:

* The bar in red indicates where Shree Ganesh Biotech (India)'s Beta falls into.


BOM:539470
46GF Score
Shree Ganesh Biotech (India) Ltd BOM:539470
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shree Ganesh Biotech (India) Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.9186 mean?
Shree Ganesh Biotech (India) (BOM:539470) has a Beta of 1.9186 as of Jul. 01, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Shree Ganesh Biotech (India) and its competitors.
Is Shree Ganesh Biotech (India)'s Beta too high?
Shree Ganesh Biotech (India)'s current Beta is 1.9186. Overall, Shree Ganesh Biotech (India) has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shree Ganesh Biotech (India)'s Beta compare to CTVA and CF?
Shree Ganesh Biotech (India)'s Beta of 1.9186 can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for an Agriculture company?
A good Beta depends on the Agriculture industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Shree Ganesh Biotech (India) and its competitors. Shree Ganesh Biotech (India)'s current Beta is 1.9186. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shree Ganesh Biotech (India) stock overvalued right now?
Based on GuruFocus' analysis, Shree Ganesh Biotech (India) (BOM:539470) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹0.20, compared to a current price of ₹0.56 — trading 180% above its estimated fair value. The current Beta is 1.9186. Shree Ganesh Biotech (India)'s overall GF Score™ is 46/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Shree Ganesh Biotech (India) (BOM:539470), the current Beta is 1.9186 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shree Ganesh Biotech (India) (BOM:539470) Overvalued in 2026?

Based on GuruFocus' analysis, Shree Ganesh Biotech (India) stock appears to be overvalued. The current stock price of ₹0.56 is trading 180% above its estimated GF Value™ of ₹0.20. GuruFocus considers Shree Ganesh Biotech (India) to be Significantly Overvalued.

Key valuation signals for BOM:539470:

  • Beta: 1.9186
  • GF Value™: ₹0.20 vs. price of ₹0.56 (180% above fair value)
  • GF Score™: 46/100 with 2 warning signs

No single metric tells the full story. See the BOM:539470 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shree Ganesh Biotech (India) Business Description

Address Cubicle No.:126,3/2 ,75C,Park Street, 3rd Floor, Kamdhenu Building, Kolkata, WB, IND, 700016
Shree Ganesh Biotech (India) Ltd is an India-based company mainly engaged in the business of production, processing and marketing of high-quality hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum, etc.
46GF Score

Get the complete analysis for BOM:539470

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹0.56
Price
₹0.20
GF Value